LuciQuiza

LuciQuiza uses and dosage

LuciQuiza (Quizartinib), generic Vanflyta is a prescription medicine used to treat treatment of newly diagnosed acute myeloid leukemia (AML) in adult patients with a confirmed FLT3 internal tandem duplication (ITD)-positive mutation. Quizartinib is utilized as part of a combination regimen with standard chemotherapy and as maintenance monotherapy following the completion of chemotherapy. LuciQuiza manufactured by Lucius Pharma Ltd. in Laos. Quizartinib has to take orally once a daily with or without food as directed by patients doctor.

LuciQuiza side effects

The most common side effects of Quizartinib are: Nausea, vomiting, diarrhea, abdominal pain, mouth sores, decreased appetite, headache, or trouble sleeping.

Originator brand

Vanflyta by DAIICHI SANKYO INC

Made by

Lucius Pharma

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.